Manuel Mendizabal - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Manuel Mendizabal

Showing results (71-80 of 82) with videos related to

Pageof 9

Sort By:

Hepatology (Baltimore, Md.)|March 13, 2021

Outcome of COVID-19 in Patients With Autoimmune Hepatitis: An International Multicenter StudyCumali Efe, Renumathy Dhanasekaran, Craig Lammert, et al.

European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|February 23, 2023

Norfloxacin prophylaxis effect on multidrug resistance in patients with cirrhosis and bacterial infectionsSebastián Marciano, Maria N Gutierrez-Acevedo, Sabrina Barbero, et al.

Annals of Hepatology|April 8, 2023

Clinical and microbiological characteristics of bacterial infections in patients with cirrhosis. A prospective cohort study from Argentina and UruguayCarolina Vazquez, María Nelly Gutierrez-Acevedo, Sabrina Barbero, et al.

Hepatology (Baltimore, Md.)|May 14, 2022

Liver injury after SARS-CoV-2 vaccination: Features of immune-mediated hepatitis, role of corticosteroid therapy and outcomeCumali Efe, Anand V Kulkarni, Benedetta Terziroli Beretta-Piccoli, et al.

Hepatology (Baltimore, Md.)|May 6, 2026

Exploring the interaction between metabolic dysfunction and alcohol-associated hepatitis: A global studyVania Cari, María Ignacia Perez, Ignacio Tellez, et al.

Gut|February 26, 2025

Gene score to quantify systemic inflammation in patients with acutely decompensated cirrhosisJonel Trebicka, Ferran Aguilar, Alberto Queiroz Farias, et al.

JHEP Reports : Innovation in Hepatology|July 17, 2023

MELD 3.0 adequately predicts mortality and renal replacement therapy requirements in patients with alcohol-associated hepatitisLuis Antonio Díaz, Eduardo Fuentes-López, Gustavo Ayares, et al.

Hepatology (Baltimore, Md.)|April 12, 2024

An artificial intelligence-generated model predicts 90-day survival in alcohol-associated hepatitis: A global cohort studyWinston Dunn, Yanming Li, Ashwani K Singal, et al.

Gastroenterology|June 1, 2023

Genetic Ancestry, Race, and Severity of Acutely Decompensated Cirrhosis in Latin AmericaAlberto Queiroz Farias, Anna Curto Vilalta, Patricia Momoyo Zitelli, et al.

Liver International : Official Journal of the International Association for the Study of the Liver|November 30, 2021

Effects of immunosuppressive drugs on COVID-19 severity in patients with autoimmune hepatitisCumali Efe, Craig Lammert, Koray Taşçılar, et al.

Pageof 9

Search research articles

Showing results (71-80 of 82) with videos related to

Sort By:

Pageof 9

Hepatology (Baltimore, Md.)|March 13, 2021

Outcome of COVID-19 in Patients With Autoimmune Hepatitis: An International Multicenter StudyCumali Efe, Renumathy Dhanasekaran, Craig Lammert, et al.

European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|February 23, 2023

Norfloxacin prophylaxis effect on multidrug resistance in patients with cirrhosis and bacterial infectionsSebastián Marciano, Maria N Gutierrez-Acevedo, Sabrina Barbero, et al.

Annals of Hepatology|April 8, 2023

Hepatology (Baltimore, Md.)|May 14, 2022

Liver injury after SARS-CoV-2 vaccination: Features of immune-mediated hepatitis, role of corticosteroid therapy and outcomeCumali Efe, Anand V Kulkarni, Benedetta Terziroli Beretta-Piccoli, et al.

Hepatology (Baltimore, Md.)|May 6, 2026

Exploring the interaction between metabolic dysfunction and alcohol-associated hepatitis: A global studyVania Cari, María Ignacia Perez, Ignacio Tellez, et al.

Gut|February 26, 2025

Gene score to quantify systemic inflammation in patients with acutely decompensated cirrhosisJonel Trebicka, Ferran Aguilar, Alberto Queiroz Farias, et al.

JHEP Reports : Innovation in Hepatology|July 17, 2023

MELD 3.0 adequately predicts mortality and renal replacement therapy requirements in patients with alcohol-associated hepatitisLuis Antonio Díaz, Eduardo Fuentes-López, Gustavo Ayares, et al.

Hepatology (Baltimore, Md.)|April 12, 2024

An artificial intelligence-generated model predicts 90-day survival in alcohol-associated hepatitis: A global cohort studyWinston Dunn, Yanming Li, Ashwani K Singal, et al.